Delivery Order SPE2DB22D2009-SPE2DB25FL7XY

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,710.70, is for the supply of Imitrex 6 mg/0.5 ml pen injections to support military healthcare programs. The contract has an ultimate completion date of May 30, 2024. Amerisourcebergen holds a separate $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml pen injectors. The fixed-price delivery order, valued at $12,343.56, has an ultimate completion date of September 20, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, to deliver a wide range of medical...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,688.76 firm fixed-price delivery order is for the supply of Imitrex 6 mg/0.5 ml prefilled injection pens, without any set-aside designation. The contract has an ultimate completion date of September 18, 2024. Amerisourcebergen is a significant supplier of pharmaceutical products and medical supplies to various government...
This federal contract award, valued at $9,383.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Imitrex 6 mg/0.5 ml pen injections. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This federal contract award, worth $9,446.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Imitrex 6 mg/0.5 ml pen injections, with a completion date of February 18, 2025. The contract is a Firm Fixed Price arrangement and was not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,268.17, is for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML medication. This is a firm fixed-price delivery order contract with a completion date of March 8, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $1,397.71, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a prescription medication. This delivery order contract has a firm fixed price pricing type and an ultimate completion date of September 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML. The contract, valued at $1,399.20, is a firm fixed-price delivery order with a completion date of July 28, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, the prime contractor, holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen). The contract is for the delivery of a pharmaceutical product, Imitrex 6 mg/0.5 mL pen injections, with a ceiling value of $2,773.68 and a completion date of April 17, 2024. The contract is a Firm Fixed Price Delivery Order, awarded without any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML. The delivery order has a total ceiling value of $2,828.81 and a completion date of November 1, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL7XY
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,873.98 firm fixed-price delivery order contract is for the supply of Imitrex 6 mg/0.5 ml pen injections. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:00 PM